These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 34519533)

  • 1. Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.
    Cakir M; Obernier K; Forget A; Krogan NJ
    mSystems; 2021 Oct; 6(5):e0038821. PubMed ID: 34519533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Antifungals for Host-Directed Antiviral Therapy?
    Schloer S; Goretzko J; Rescher U
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics to study macrophage response to viral infection.
    Nyman TA; Matikainen S
    J Proteomics; 2018 May; 180():99-107. PubMed ID: 28647517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Spectrometry-Based Proteomics of Fungal Pathogenesis, Host-Fungal Interactions, and Antifungal Development.
    Ball B; Bermas A; Carruthers-Lay D; Geddes-McAlister J
    J Fungi (Basel); 2019 Jun; 5(2):. PubMed ID: 31212923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive systems biology approach to broad-spectrum, host-directed drug target discovery in infectious diseases.
    Felciano RM; Bavari S; Richards DR; Billaud JN; Warren T; Panchal R; Krämer A
    Pac Symp Biocomput; 2013; ():17-28. PubMed ID: 23424108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic approaches towards the development of host-directed antiviral therapeutics.
    Prussia A; Thepchatri P; Snyder JP; Plemper RK
    Int J Mol Sci; 2011; 12(6):4027-52. PubMed ID: 21747723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
    Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
    Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases.
    Jean Beltran PM; Federspiel JD; Sheng X; Cristea IM
    Mol Syst Biol; 2017 Mar; 13(3):922. PubMed ID: 28348067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.
    Chiang CY; Uzoma I; Moore RT; Gilbert M; Duplantier AJ; Panchal RG
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-Directed Antiviral Therapy.
    Kumar N; Sharma S; Kumar R; Tripathi BN; Barua S; Ly H; Rouse BT
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing host-based therapeutics to control coronavirus and influenza virus.
    Li CC; Wang XJ; Wang HR
    Drug Discov Today; 2019 Mar; 24(3):726-736. PubMed ID: 30711575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of host-bacterial interactions: new insights from dual perspectives.
    Sukumaran A; Woroszchuk E; Ross T; Geddes-McAlister J
    Can J Microbiol; 2021 Mar; 67(3):213-225. PubMed ID: 33027598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.
    Terrier O; Slama-Schwok A
    Adv Exp Med Biol; 2021; 1322():195-218. PubMed ID: 34258742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects.
    Zumla A; Rao M; Wallis RS; Kaufmann SH; Rustomjee R; Mwaba P; Vilaplana C; Yeboah-Manu D; Chakaya J; Ippolito G; Azhar E; Hoelscher M; Maeurer M;
    Lancet Infect Dis; 2016 Apr; 16(4):e47-63. PubMed ID: 27036359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-directed drug targeting of factors hijacked by pathogens.
    Schwegmann A; Brombacher F
    Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host directed therapies: COVID-19 and beyond.
    Tripathi D; Sodani M; Gupta PK; Kulkarni S
    Curr Res Pharmacol Drug Discov; 2021; 2():100058. PubMed ID: 34870156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.